Niklas Victoria Ninon Olivia Acquires Stock Options in FibroBiologics, Inc.

Niklas Victoria Ninon Olivia, a director at FibroBiologics, Inc., acquired 30,803 stock options on June 23, 2026. The options, with a right to buy underlying Common Stock, have an exercise price of $0.7503 and will vest in full on the earlier of the first anniversary of the grant date or the next annual meeting. The transaction is reported on Form 4, with the ownership nature designated as direct (D) and the transaction code as A (all others). Following this acquisition, Olivia directly owns 30,803 shares. The filing also includes details about the issuer, FibroBiologics, Inc. (FBLG), and standard reporting owner information.